FDA Investigator Kimberly A Coward
Kimberly A Coward has inspections in 1 countries as of 27 Sep 2023. Kimberly A Coward has collaborated with a combined 1452 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
115
Last Inspection Date:
27 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Ali A Patino,
Amy Kim,
Andrew J Molesky,
Anna M Alexander,
Anthony M Criscuolo, Jr,
Anthony R Rauert,
Anthony W Thomas,
Atul J Agrawal,
Ayorinde O Babalola,
Barbara J Maulfair,
Benjamin Bustamante,
Brian M Brodman,
Brittney Hu,
Cara M Minelli,
Christian Parra,
Christine M Rivera,
Craig W Swanson,
Daniel Green,
David R Delucia,
Diane B Radice,
Donyel M Jones,
Edwin A Evangelista,
Emilio Z Azukwu,
Eric J Reisenauer,
Erica B Raphael,
Frank Verni,
Gabriel Feng,
Gray,
Huascar Batista,
Jana J Lau,
Jananiga Vanniyasingam,
Jane Chen,
Jason Kwong,
Jennifer L Custodio,
John P Sakowski,
Joseph Duca,
Joseph Maselli,
Juliana Falla,
Justin C Fuller,
King,
Krystal O Ogunremi,
Laishan L Lam,
Lawrence R Johnson,
Marjorie D Schultz,
Maximillian Lucci,
Melissa N Gregorio,
Melka F Argaw,
Meredith P Soehl, Investigator,
Michael R Dominick,
Neil J Bonzagni, PhD MPH,
Nicole Vaught,
Onieka T Carpenter,
Pasquale L Leone,
Peter M Trunk,
Peter R Caparelli,
Peter R Lenahan,
Randolph Campos Santiago,
Raymond Liu,
Raymond M Lam,
Rita F Monfort,
Ronald Ifraimov,
Samuel A Francis,
Sands,
Sarah A Meehan,
Satheesh Thomas,
Schultz,
Seemay A Lee,
Shamel Jaime,
Sharon Ferraro,
Sherri J Liu,
Sonia E Ortiz,
Spiridoula Dimopoulos,
State Agency,
Sunita Vij,
Susan M Halsted,
Suwaskie S Smith,
Taina Pierre Pierre,
Tara K Carmody,
Thomas Cote,
Tracy M Portelli,
Tressa T Lewis,
Vaishali J Patel,
Wai H Lam,
William V Thompson,
Willy A Orantes,
Yuyan Liang,
Yvonne M Santiago
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more